| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/24/2013 | US20130023508 Hyaluronic acid based copolymers |
| 01/24/2013 | US20130023507 Hyaluronic acid based copolymers |
| 01/24/2013 | US20130023485 Parenteral formulations of peptides for the treatment of systematic lupus erythematosus |
| 01/24/2013 | US20130022679 Controlled Release and Taste Masking Oral Pharmaceutical Composition |
| 01/24/2013 | US20130022672 Stabilized Amorphous Forms of Imatinib Mesylate |
| 01/24/2013 | US20130022661 Bio-remodable bone augmentation device and method |
| 01/24/2013 | US20130022552 Blood clotting composition and method of use |
| 01/24/2013 | CA2842582A1 Water-based plaster |
| 01/24/2013 | CA2842550A1 Intravaginal devices for drug delivery |
| 01/24/2013 | CA2842323A1 Long acting biologically active luteinizing hormone (lh) compound |
| 01/24/2013 | CA2842321A1 Engineered microbe-targeting molecules and uses thereof |
| 01/24/2013 | CA2842306A1 Intraperitoneally-administered nanocarriers that release their therapeutic load based on the inflammatory environment of cancers |
| 01/24/2013 | CA2842277A1 Topical oily foam formulations |
| 01/24/2013 | CA2842195A1 Fty720 increases cd74 expression and sensitizes cancer cells to anti-cd74 antibody-mediated cell death |
| 01/24/2013 | CA2841964A1 Methods of treating pain |
| 01/24/2013 | CA2841851A1 Composition and method for treating hpv |
| 01/24/2013 | CA2841367A1 Oral compositions comprising an antacid, an anaesthetic and an inorganic matrix comprising silicon dioxide and titanium dioxide |
| 01/24/2013 | CA2841313A1 Sugar alcohol-based crosslinking reagents, macromolecules, therapeutic bioconjugates, and synthetic methods thereof |
| 01/23/2013 | EP2548916A1 Organic/inorganic composite filler and manufacturing method therefor |
| 01/23/2013 | EP2548900A1 Cationic nanogels for biotechnological uses |
| 01/23/2013 | EP2548895A1 Modified saccharides |
| 01/23/2013 | EP2548583A2 Method of treating ovarian and renal cancer using antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen |
| 01/23/2013 | EP2548582A1 Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation |
| 01/23/2013 | EP2548581A2 A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof |
| 01/23/2013 | EP2548566A1 Composition for transnasal administration and method for producing same |
| 01/23/2013 | EP2548556A1 Method for improving dissolvability of anticoagulant |
| 01/23/2013 | EP2547765A1 Beta-propiolactone for inactivation of viruses in pharmaceutical pancreatic enzyme preparations |
| 01/23/2013 | EP2547367A1 System for improved delivery of gene modulating compounds |
| 01/23/2013 | EP2547333A2 Stable bortezomib formulations |
| 01/23/2013 | EP2547325A2 Spray-pumpable composition suitable for topical skin application |
| 01/23/2013 | EP2547323A2 Pharmaceutical composition for treatment of increased intraocular pressure |
| 01/23/2013 | EP2547221A2 Fat-binding compositions |
| 01/23/2013 | EP2158900B1 Polymeric delivery formulations of leuprolide with improved efficacy |
| 01/23/2013 | CN1919339B Cucurbitacin nano preparation comprising protein, preparation method and use thereof |
| 01/23/2013 | CN1784217B Binder composition and method for processing poorly compressible drugs into tablets of predetermined hardness and friability |
| 01/23/2013 | CN102892734A Improved methods for preparing squalene |
| 01/23/2013 | CN102892427A Excipients for stabilising viral particles, polypeptides or biological material |
| 01/23/2013 | CN102892424A Stabilisation of viral particles |
| 01/23/2013 | CN102892414A Carotenoid-containing composition and production method therefor |
| 01/23/2013 | CN102892412A Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof |
| 01/23/2013 | CN102892411A Pharmaceutical oral dosage form containing a synthetic oligosaccharide |
| 01/23/2013 | CN102892410A Pharmaceutical composition of ibuprofen for injection |
| 01/23/2013 | CN102892408A Water-free pharmaceutical compositions suitable for local anaesthetics |
| 01/23/2013 | CN102892405A Orally administrable film dosage forms containing ondansetron |
| 01/23/2013 | CN102892310A Fat-binding compositions |
| 01/23/2013 | CN102892306A Method for preparing composition including compound containing vanillin and ethylvanillin, composition thus obtained and use thereof |
| 01/23/2013 | CN102887992A Polyester/polyethylene glycol block copolymer containing side cinnamoyl group and application thereof |
| 01/23/2013 | CN102887546A Water-soluble ferroferric oxide nano particle, preparation method and application thereof |
| 01/23/2013 | CN102886053A Composite nano capsule having ultrasonic/MRI (Magnetic Resonance Imaging) dual response and preparation method thereof |
| 01/23/2013 | CN102886052A Long lasting drug formulations |
| 01/23/2013 | CN102886049A Nanobiomaterial, its preparation method and nucleic acid compound |
| 01/23/2013 | CN102886048A Building method for medicament transportation or radiography carrier containing coat protein and inorganic nanoparticles |
| 01/23/2013 | CN102886047A Baicalein combination and preparation method thereof |
| 01/23/2013 | CN102886046A Preparation method of fat-soluble chemotherapeutic medicament loaded on calcium phosphate nano carrier and application of fat-soluble chemotherapeutic medicament in preparation of antitumor medicaments |
| 01/23/2013 | CN102885932A Heartleaf houttuynia herb injection and preparation method thereof |
| 01/23/2013 | CN102885865A Antiallergic tablet |
| 01/23/2013 | CN102885853A Ointment for treating skin disease |
| 01/23/2013 | CN102885852A Povidone iodine ointment and preparation method thereof |
| 01/23/2013 | CN102885823A Stable pharmaceutical composition containing sodium tanshinone IIA sulfonate |
| 01/23/2013 | CN102885813A Pharmaceutical compositions for the treatment of hyper-proliferative disorders |
| 01/23/2013 | CN102885812A Lappaconite hydrobromide sustained-release tablets and preparation method thereof |
| 01/23/2013 | CN102885804A Dopamine prodrug composition and preparation method thereof |
| 01/23/2013 | CN102885799A Preparation method of gelatine-free double-layer hollow capsule |
| 01/23/2013 | CN102885797A Composition containing pravastatin calcium as well as preparation method and application thereof |
| 01/23/2013 | CN102885795A Trimetazidine dihydrochloride sustained-release tablet and preparation method thereof |
| 01/23/2013 | CN102885794A Buccal interferon tablet and preparation method thereof |
| 01/23/2013 | CN102885793A Nifuratel compound tablet and preparation method thereof |
| 01/23/2013 | CN102885791A Method for preparing fexofenadine hydrochloride orally disintegrating tablet |
| 01/23/2013 | CN102885788A Linezolid tablets in stable crystal form and preparation method thereof |
| 01/23/2013 | CN102885787A Moxifloxacin hydrochloride tablets for preventing color change and cracking and preparation method thereof |
| 01/23/2013 | CN102885786A Mixed micelle freeze-dried preparation loaded with docetaxel and preparation method thereof |
| 01/23/2013 | CN102885785A Adriamycin-containing nanometer medicament microspheres and preparation method thereof |
| 01/23/2013 | CN102885784A Method for preparing microspheres by using oil-in-nanoparticle mixed suspension-nanometer medicament-in-oil |
| 01/23/2013 | CN102885783A Nanometer medicament microspheres |
| 01/23/2013 | CN102885782A Growth hormone-containing nanometer medicament microspheres and preparation method thereof |
| 01/23/2013 | CN102885781A Solid dispersion of arctigenin and oral solid preparation |
| 01/23/2013 | CN102885780A Method for improving bioavailability of resveratrol |
| 01/23/2013 | CN102885778A Active carbon paclitaxel nano-drug delivery system, and preparation method and application thereof |
| 01/23/2013 | CN102885777A Efficient florfenicol powder composition and preparation method thereof |
| 01/23/2013 | CN102885776A Nanoparticle with simulated outer cell membrane structure as well as preparation method and application thereof |
| 01/23/2013 | CN102885774A Prasugrel composition and preparation method thereof |
| 01/23/2013 | CN102885772A Docetaxel-loading mixed micelle preparation and preparation method thereof |
| 01/23/2013 | CN102885771A High-concentration vitamin C injection solution and preparation method thereof |
| 01/23/2013 | CN102885770A Novel gatifloxacin eye drop and preparation method thereof |
| 01/23/2013 | CN102885769A Novel pranoprofen eye drop and preparation method thereof |
| 01/23/2013 | CN102885768A Pranoprofen in-situ gelling eye drop and preparation method thereof |
| 01/23/2013 | CN102885767A Novel olopatadine hydrochloride eye drop and preparation method thereof |
| 01/23/2013 | CN102885766A Dexketoprofen injection and preparation method thereof |
| 01/23/2013 | CN102885763A Novel mupirocin ointment pharmaceutical composition |
| 01/23/2013 | CN102885760A Hydrobromic acid galanthamine controlled-release dry suspension and preparation method thereof |
| 01/23/2013 | CN102885759A Risedronate sodium sustained-release preparation and preparation method thereof |
| 01/23/2013 | CN102885700A Hygroscopic humectant capable of replacing hyaluronic acid |
| 01/23/2013 | CN102579349B Torasemide liposome injection |
| 01/23/2013 | CN102440959B Pidotimod liposome solid preparation |
| 01/23/2013 | CN102440958B Ibuprofen sodium liposome solid preparation and preparation method thereof |
| 01/23/2013 | CN102406606B Solid quetiapine fumarate liposome preparation |
| 01/23/2013 | CN102397253B Clopidogrel bisulfate liposome solid preparation |
| 01/23/2013 | CN102397249B Cefetamet pivoxil hydrochloride liposome solid preparation |
| 01/23/2013 | CN102327238B Levocarnitine composition for injection and preparation method of levocarnitine composition |
| 01/23/2013 | CN102319215B Vecuronium bromide liposome injection |